Figure 3. FLE treatment combined with low-dose tetracycline
A) A 19 year old male patient presenting with baseline acne severity of IGA 3. The patient was previously treated with topical treatment and tetracycline without effect. Wishing fast response and unable to meet frequent blood analysis required for standard dose of isotretinoin therapy. The patient was started in low-dose isotretinoin combined with FLE treatment. B) A 19 year old male patient presenting with baseline acne severity of IGA 3, previously undergoing topical and tetracycline therapy without effect and discontinued isotretinoin treatment due to adverse effects. The patient was started on tetracycline combined with FLE treatment. C) A 17 year old male patient presenting with baseline acne severity of IGA 3. The patient was previously treated with topical treatment without effect. Now wishing a fast response, the patient was started on tetracycline combined with FLE treatment. D) A 24 year old female patient presenting with baseline acne severity of IGA 3. The patient was previously treated with topical treatment, tetracycline with norelgestromin/ethinylestradiol (Evra), without effect. The patient was started on tetracycline and norelgestromin/ethinyl estradiol (BCP) combined with FLE treatment. Appearance of the skin as presented at each evaluation; baseline (upper row), week 6 (second row from top), week 12 (third row from top), week 33 (fourth row from top), and week 52 (bottom row).